Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 1
1965 2
1968 1
1969 3
1970 4
1972 1
1978 1
1984 1
1986 1
1989 1
1990 1
1991 2
1994 1
1997 2
1999 3
2000 1
2002 1
2004 1
2005 1
2006 1
2007 1
2009 1
2012 1
2013 3
2014 3
2015 5
2016 6
2017 11
2018 6
2019 9
2020 6
2021 7
2022 13
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
ABO-incompatible pediatric kidney transplantation without antibody removal.
Kawamura T, Hamasaki Y, Takahashi Y, Hashimoto J, Kubota M, Muramatu M, Itabashi Y, Hyodo Y, Ohashi Y, Aikawa A, Sakai K, Shishido S. Kawamura T, et al. Among authors: hyodo y. Pediatr Nephrol. 2020 Jan;35(1):95-102. doi: 10.1007/s00467-019-04376-7. Epub 2019 Oct 31. Pediatr Nephrol. 2020. PMID: 31673829
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, Ishiguro C, Izumi C, Noguchi T, Shiraiwa T, Nishioka N, Fujii K, Iwakura K, Tomonaga O, Kobayashi K, Takihata M, Yumoto K, Takase H, Himi T, Shimizu I, Murakami T, Wagatsuma K, Sato K, Hiramatsu T, Akabame S, Hata S, Asakura M, Kawabata T, Omae K, Ito S, Kitakaze M; DAPPER Investigators. Yoshihara F, et al. EClinicalMedicine. 2023 Nov 27;66:102334. doi: 10.1016/j.eclinm.2023.102334. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38192595 Free PMC article.
Effects of Growth Hormone Treatment on Lipid Profiles.
Kubo T, Furujo M, Takahashi K, Hyodo Y, Tsuchiya H, Hattori M, Fujinaga S, Urayama K. Kubo T, et al. Among authors: hyodo y. Indian J Pediatr. 2018 Apr;85(4):261-265. doi: 10.1007/s12098-017-2509-8. Epub 2017 Nov 11. Indian J Pediatr. 2018. PMID: 29127617
Usefulness of non-fasting lipid parameters in children.
Kubo T, Takahashi K, Furujo M, Hyodo Y, Tsuchiya H, Hattori M, Fujinaga S, Urayama K. Kubo T, et al. Among authors: hyodo y. J Pediatr Endocrinol Metab. 2017 Jan 1;30(1):77-83. doi: 10.1515/jpem-2016-0271. J Pediatr Endocrinol Metab. 2017. PMID: 27977407
102 results